These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6183291)

  • 1. Human newborns are deficient in natural killer activity.
    Kaplan J; Shope TC; Bollinger RO; Smith J
    J Clin Immunol; 1982 Oct; 2(4):350-5. PubMed ID: 6183291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2.
    Cohen BL; Orn A; Gronvik KO; Gidlund M; Wigzell H; Murgita RA
    Scand J Immunol; 1986 Feb; 23(2):211-23. PubMed ID: 2419966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections.
    Georgeson GD; Szony BJ; Streitman K; Kovács A; Kovács L; László A
    Eur J Pediatr; 2001 Aug; 160(8):478-82. PubMed ID: 11548185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures.
    Heiskala M
    Immunology; 1987 Feb; 60(2):167-72. PubMed ID: 2434416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell function of human neonatal lymphocytes.
    Uksila J; Lassila O; Hirvonen T
    Clin Exp Immunol; 1982 Jun; 48(3):649-54. PubMed ID: 6180853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host defense system in the human newborn: the role of interferon and the natural killer cell.
    Read SE; Williams BR
    Clin Invest Med; 1984; 7(4):259-62. PubMed ID: 6085299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
    Montagna D; Maccario R; Ugazio AG; Mingrat G; Burgio GR
    Clin Exp Immunol; 1988 Jan; 71(1):177-81. PubMed ID: 2964956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific recognition of virus-infected cells by paired NK receptors.
    Arase H; Lanier LL
    Rev Med Virol; 2004; 14(2):83-93. PubMed ID: 15027001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon and natural killer cell activity in patients with exanthem subitum.
    Takahashi K; Segal E; Kondo T; Mukai T; Moriyama M; Takahashi M; Yamanishi K
    Pediatr Infect Dis J; 1992 May; 11(5):369-73. PubMed ID: 1378586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus.
    Hayward A; Laszlo M; Vafai A
    J Immunol; 1989 Feb; 142(4):1139-43. PubMed ID: 2536766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.
    Leibson PJ; Hunter-Laszlo M; Douvas GS; Hayward AR
    J Clin Immunol; 1986 May; 6(3):216-24. PubMed ID: 3013922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
    Reiter Z
    J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha.
    Einhorn S; Ahre A; Blomgren H; Johansson B; Mellstedt H; Strander H
    Int J Cancer; 1982 Aug; 30(2):167-72. PubMed ID: 6182111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD
    Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
    Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
    Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
    Neighbour PA; Grayzel AI; Miller AE
    Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action.
    Chen HY; Sato T; Fuse A; Kuwata T; Content J
    J Gen Virol; 1981 Jan; 52(Pt 1):177-81. PubMed ID: 6167662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activity in tuberculosis.
    Onwubalili JK; Scott GM
    Br J Dis Chest; 1985 Jan; 79(1):67-76. PubMed ID: 2580544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin-dependent T-lymphocyte and natural killer cytotoxic deficiencies in human newborns.
    Lubens RG; Gard SE; Soderberg-Warner M; Stiehm ER
    Cell Immunol; 1982 Nov; 74(1):40-53. PubMed ID: 6186405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.